These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9136611

  • 1. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
    Otsubo T, Miyaoka H, Kamijima K, Onuki M, Ishii M, Mitamura K.
    Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.
    Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD.
    Mol Psychiatry; 2002; 7(9):942-7. PubMed ID: 12399946
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 4. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S, Ferreri M, Cabanac F, Bitton M.
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [Abstract] [Full Text] [Related]

  • 5. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Laguno M, Blanch J, Murillas J, Blanco JL, León A, Lonca M, Larrousse M, Biglia A, Martinez E, García F, Miró JM, de Pablo J, Gatell JM, Mallolas J.
    Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
    [Abstract] [Full Text] [Related]

  • 6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Dec; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of depression in Otocac ten years after the war].
    Marinić T, Ozvacić Z, Katić M, Polasek O, Lazić D.
    Acta Med Croatica; 2007 Feb; 61(1):25-31. PubMed ID: 17593637
    [Abstract] [Full Text] [Related]

  • 8. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M, Indest DW, Blackwell A, Whitehead AJ, Hauser P.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [Abstract] [Full Text] [Related]

  • 9. Occurrence, course and risk factors of depression during antiviral treatment for chronic hepatitis C in patients with inherited bleeding disorders: a prospective study.
    Fransen Van De Putte DE, Fischer K, Posthouwer D, Van Erpecum K, Mauser-Bunschoten EP.
    Haemophilia; 2009 Mar 15; 15(2):544-51. PubMed ID: 19175422
    [Abstract] [Full Text] [Related]

  • 10. [Acute renal insufficiency in renal transplants treated with interferon-alpha for chronic hepatitis C].
    Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Tkaczuk J, Durand D, Suc JM.
    Nephrologie; 1996 Mar 15; 17(4):247-54. PubMed ID: 8768457
    [Abstract] [Full Text] [Related]

  • 11. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
    Heinze S, Egberts F, Rötzer S, Volkenandt M, Tilgen W, Linse R, Boettjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Hinzpeter A, Hauschild A, Schaefer M.
    J Immunother; 2010 Jan 15; 33(1):106-14. PubMed ID: 19952950
    [Abstract] [Full Text] [Related]

  • 12. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
    Lang JP, Meyer N, Doffoel M.
    Encephale; 2003 Jan 15; 29(4 Pt 1):362-5. PubMed ID: 14615706
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H.
    J Gastroenterol; 2004 Jan 15; 39(5):455-60. PubMed ID: 15175944
    [Abstract] [Full Text] [Related]

  • 14. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
    Beratis S, Katrivanou A, Georgiou S, Monastirli A, Pasmatzi E, Gourzis P, Tsambaos D.
    J Psychosom Res; 2005 Jan 15; 58(1):15-8. PubMed ID: 15771865
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 15; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 16. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA, Tan D, Mirsal H, Pektas O, Beyazyurek M.
    J Psychopharmacol; 2005 Jan 15; 19(1):102-5. PubMed ID: 15671136
    [Abstract] [Full Text] [Related]

  • 17. [Depression during interferon therapy in renal cell cancer patients--comparison with chronic hepatitis C patients].
    Sakamoto H, Inoue K, Shimada M, Yoshida H, Otsubo T, Miyaoka H, Kamizima K, Ishii M, Mitamura K.
    Nihon Hinyokika Gakkai Zasshi; 2000 Sep 15; 91(9):611-7. PubMed ID: 11068424
    [Abstract] [Full Text] [Related]

  • 18. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K.
    Hepatology; 2003 Feb 15; 37(2):443-51. PubMed ID: 12540795
    [Abstract] [Full Text] [Related]

  • 19. The effect of depression on quality of life of patients with type II diabetes mellitus.
    Eren I, Erdi O, Sahin M.
    Depress Anxiety; 2008 Feb 15; 25(2):98-106. PubMed ID: 17311266
    [Abstract] [Full Text] [Related]

  • 20. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis.
    Hosoda S, Takimura H, Shibayama M, Kanamura H, Ikeda K, Kumada H.
    Psychiatry Clin Neurosci; 2000 Oct 15; 54(5):565-72. PubMed ID: 11043807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.